- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03880071
DIalectical Behavior Therapy and Acceptance Commitment Therapy Short Program for BOrderLine persOnality Disorder (DIABOLO)
Efficacy of a Dialectical Behavior Therapy and Acceptance Commitment Therapy Short Program for Prevention of Suicidal Behavior in Patients With Borderline Personality Disorder
According to the World Health Organization 1 death by suicide occurs every 40 seconds, leading suicide prevention to one of the public health priority.
Borderline personality disorder (BPD) is a common condition affecting 6% of the population.
This disorder is characterized by unstable emotions, unstable mood, difficulties with relationship and feer of abandonment.
BPD is also the psychopathology the most related to suicidal attempts. Indeed, up to 50% of the patients admitted to hospital after a suicide attempt are diagnosis with a BPD.
Negative interpersonal events (events occurring between two people) are known as the main stressor that trigger a suicidal attempt.
People with a BPD are highly sensitive to it. Unfortunately, patient care for this disorder is limited. Pharmacological strategies didn't show any efficacy and psychotherapies, although proven effective, are difficult to set up.
As BPD is strongly related to suicidal attempts it appears to be a good model to study suicidal behavior. Thus, this study could improve knowledge in this field.
Suicidal behavior in patients receiving the standard therapy (dialectic behavioural therapy: DBT) will be compared to patients receiving dialectical behavior therapy and acceptance commitment therapy (ACT).
Clinical data reflecting how the participant is feeling will be collected as well.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
An emotional dysregulation has been linked to suicidal behavior in patients with BPD.
Up to this date, no program had combined dialectical behavior therapy with acceptance commitment therapy.
DBT aims to teach skills in four different fields : mindfulness, emotional regulation, distress tolerance and interpersonal efficiency.
ACT helps to develop metacognitive skills and to identify what makes sense in one's life.
Because 75% of BPD patients are women, the study will only focus on them.
Patients will be evaluated during 4 visits :
- Inclusion : 1 or 2 weeks before the first session of therapy. During this visit patients will undergo a clinical exam and will complete questionnaires.
- First follow-up visit : 6 months after the first session (for the experimental group) or 12 months after the first session (for the control group). During this visit will undergo a clinical exam and will complete questionnaires. Therapeutic processes, therapy satisfaction and cost- effectiveness ratio will be evaluated
- Second follow-up visit : 12 months after the first sessions (for the experimental group) or 18 months after the first session (for the control group). During this visit will undergo a clinical exam and will complete questionnaires. Therapeutic processes, and cost- effectiveness ratio will be evaluated
- Third follow-up visit : 18 months after the first session (for the experimental group) or 24 months after the first session (for the control group). During this visit will undergo a clinical exam and will complete questionnaires. Therapeutic processes, and cost- effectiveness ratio will be evaluated The hypothesis is that DBT+ ACT allows reducing suicidal recidivism, reducing economical cost linked to BPD and improving quality of life and functioning among patients.
Study Type
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Hérault
-
Montpellier, Hérault, France, 34295
- CHU Montpellier
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Being a woman
- Between 18 and 50 years old
- Clinical diagnosis of BPD using the Structured Clinical Interview for DSM-IV-TR ( Diagnostic and Statistical Manual of mental disorders) Axis II Personality Disorders)
- Having signed the informed consent
- Able to realize all the visits and therapy sessions
- Able to speak, read and understand French
Exclusion Criteria:
- Life time diagnosis of schizophrenia
- Life time diagnosis of intellectual disability
- Not able to read and write
- Refusal of participation
- Subject protected by law (guardianship)
- Deprived of liberty Subject (by judicial or administrative decision)
- Not belonging to social safety system
- Exclusion period in relation to another protocol
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Non-Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: DBT + ACT group
- The experimental group (DBT+ ACT) led in Montpellier during 6 months.
|
- The experimental group (DBT+ ACT) will have: 25 therapy group sessions (1 sessions of 2 hours once a week) 25 individual interview sessions (1 sessions of 1 hour once a week) will receive 25 group sessions and 25 individual ones during 6 months.
|
Other: DBT group
The control group (DBT) led in Geneva during 12 months.
|
The control group (DBT) will have: 50 therapy group sessions (1 session of 2h30 once a week) 50 individual interview sessions (1 sessions of 1 hour once a week) |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Number of proven suicide attempts using the Columbia-Suicide severity rating scale (C-SSRS) at 1 year follow-up
Time Frame: At 1 year after the intervention
|
Evaluation and comparison of suicide attempts number before and after therapy between DBT and DBT+ACT groups with the Columbia-Suicide severity rating scale : indication of the number of proven suicide attempts and score from 0 to 5 depending on the severity of the suicide attempt
|
At 1 year after the intervention
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Evolution of suicidal symptomatology using the Columbia Suicide Severity Rating Scale (C-SSRS)
Time Frame: At one week after the intervention
|
Evaluation and comparison of suicidal symptomatology between pre-intervention and post-intervention (one week after the last session of the intervention) within the two groups (DBT versus DBT+ACT) with the 17 close-ended questions of the Columbia-Suicide severity rating scale
|
At one week after the intervention
|
Evolution of suicidal symptomatology using the Columbia Suicide Severity Rating Scale (C-SSRS)
Time Frame: At 6 months after the intervention
|
Evaluation and comparison of suicidal symptomatology between pre-intervention and post-intervention (one week after the last session of the intervention) within the two groups (DBT versus DBT+ACT) with the 17 close-ended questions of the Columbia-Suicide severity rating scale
|
At 6 months after the intervention
|
Evolution of suicidal symptomatology using the Columbia Suicide Severity Rating Scale (C-SSRS)
Time Frame: At 12 months after the intervention
|
Evaluation and comparison of suicidal symptomatology between pre-intervention and post-intervention (one week after the last session of the intervention) within the two groups (DBT versus DBT+ACT) with the 17 close-ended questions of the Columbia-Suicide severity rating scale
|
At 12 months after the intervention
|
Evolution of suicidal symptomatology (Likert scales from 0 (none) to 10 (maximum possible suicidal ideation)
Time Frame: At one week after the intervention
|
Evaluation and comparison of suicidal symptomatology between pre-intervention and post-intervention (one week after the last session of the intervention) within the two groups (DBT versus DBT+ACT
|
At one week after the intervention
|
Evolution of suicidal symptomatology (Likert scales from 0 (none) to 10 (maximum possible suicidal ideation)
Time Frame: At 6 months after the intervention
|
Evaluation and comparison of suicidal symptomatology between pre-intervention and post-intervention (one week after the last session of the intervention) within the two groups (DBT versus DBT+ACT
|
At 6 months after the intervention
|
Evolution of suicidal symptomatology (Likert scales from 0 (none) to 10 (maximum possible suicidal ideation)
Time Frame: At 12 months after the intervention
|
Evaluation and comparison of suicidal symptomatology between pre-intervention and post-intervention (one week after the last session of the intervention) within the two groups (DBT versus DBT+ACT
|
At 12 months after the intervention
|
Evolution of suicidal symptomatology (Likert scales from 0 (none) to 10 (maximal intensity of suicidal intent)
Time Frame: At one week after the intervention
|
Evaluation and comparison of intensity of suicidal intent between pre-intervention and post-intervention (one week after the last session of the intervention) within the two groups (DBT versus DBT+ACT)
|
At one week after the intervention
|
Evolution of suicidal symptomatology (Likert scales from 0 (none) to 10 (maximal intensity of suicidal intent)
Time Frame: At 6 months after the intervention
|
Evaluation and comparison of intensity of suicidal intent between pre-intervention and post-intervention (one week after the last session of the intervention) within the two groups (DBT versus DBT+ACT)
|
At 6 months after the intervention
|
Evolution of suicidal symptomatology (Likert scales from 0 (none) to 10 (maximal intensity of suicidal intent)
Time Frame: At 12 months after the intervention
|
Evaluation and comparison of intensity of suicidal intent between pre-intervention and post-intervention (one week after the last session of the intervention) within the two groups (DBT versus DBT+ACT)
|
At 12 months after the intervention
|
Evolution of suicidal symptomatology (Likert scales from 0 (none) to 10 (maximal intensity of imperious need for non-suicidal self-damaging behavior)
Time Frame: At one week after the intervention
|
Evaluation and comparison of intensity of imperious need for non-suicidal self-damaging behavior between pre-intervention and post-intervention (one week after the last session of the intervention) within the two groups (DBT versus DBT+ACT)
|
At one week after the intervention
|
Evolution of suicidal symptomatology (Likert scales from 0 (none) to 10 (maximal intensity of imperious need for non-suicidal self-damaging behavior)
Time Frame: At 6 months after the intervention
|
Evaluation and comparison of intensity of imperious need for non-suicidal self-damaging behavior between pre-intervention and post-intervention (one week after the last session of the intervention) within the two groups (DBT versus DBT+ACT)
|
At 6 months after the intervention
|
Evolution of suicidal symptomatology (Likert scales from 0 (none) to 10 (maximal intensity of imperious need for non-suicidal self-damaging behavior)
Time Frame: At 12 months after the intervention
|
Evaluation and comparison of intensity of imperious need for non-suicidal self-damaging behavior between pre-intervention and post-intervention (one week after the last session of the intervention) within the two groups (DBT versus DBT+ACT)
|
At 12 months after the intervention
|
Evolution of suicidal symptomatology (Likert scales from 0 (none) to 10 (maximal quality of perceived social support)
Time Frame: At one week after the intervention
|
Evaluation and comparison of quality of perceived social support between pre-intervention and post-intervention (one week after the last session of the intervention)within the two groups (DBT versus DBT+ACT)
|
At one week after the intervention
|
Evolution of suicidal symptomatology (Likert scales from 0 (none) to 10 (maximal quality of perceived social support)
Time Frame: At 6 months after the intervention
|
Evaluation and comparison of quality of perceived social support between pre-intervention and post-intervention (one week after the last session of the intervention)within the two groups (DBT versus DBT+ACT)
|
At 6 months after the intervention
|
Evolution of suicidal symptomatology (Likert scales from 0 (none) to 10 (maximal quality of perceived social support)
Time Frame: At 12 months after the intervention
|
Evaluation and comparison of quality of perceived social support between pre-intervention and post-intervention (one week after the last session of the intervention)within the two groups (DBT versus DBT+ACT)
|
At 12 months after the intervention
|
Evolution of suicidal symptomatology (Likert scales from 0 (none) to 10 (maximal psychological pain)
Time Frame: At one week after the intervention
|
Evaluation and comparison of psychological pain between pre-intervention and post-intervention (one week after of the last session of the intervention) within the two groups (DBT versus DBT+ACT)
|
At one week after the intervention
|
Evolution of suicidal symptomatology (Likert scales from 0 (none) to 10 (maximal psychological pain)
Time Frame: At 6 months after the intervention
|
Evaluation and comparison of psychological pain between pre-intervention and post-intervention (one week after of the last session of the intervention) within the two groups (DBT versus DBT+ACT)
|
At 6 months after the intervention
|
Evolution of suicidal symptomatology (Likert scales from 0 (none) to 10 (maximal psychological pain)
Time Frame: At 12 months after the intervention
|
Evaluation and comparison of psychological pain between pre-intervention and post-intervention (one week after of the last session of the intervention) within the two groups (DBT versus DBT+ACT)
|
At 12 months after the intervention
|
Evolution of suicidal symptomatology (Likert scales from 0 (not all characteristic of my way of being) to 10 (completely characteristic of my way of being)
Time Frame: At one week after the intervention
|
Evaluation and comparison of the evolution of intensity of each constituent trait of borderline personality disorder between pre-intervention and post-intervention (one week after the last session of the intervention) within the two groups (DBT versus DBT+ACT)
|
At one week after the intervention
|
Evolution of suicidal symptomatology (Likert scales from 0 (not all characteristic of my way of being) to 10 (completely characteristic of my way of being)
Time Frame: At 6 months after the intervention
|
Evaluation and comparison of the evolution of intensity of each constituent trait of borderline personality disorder between pre-intervention and post-intervention (one week after the last session of the intervention) within the two groups (DBT versus DBT+ACT)
|
At 6 months after the intervention
|
Evolution of suicidal symptomatology (Likert scales from 0 (not all characteristic of my way of being) to 10 (completely characteristic of my way of being)
Time Frame: At 12 months after the intervention
|
Evaluation and comparison of the evolution of intensity of each constituent trait of borderline personality disorder between pre-intervention and post-intervention (one week after the last session of the intervention) within the two groups (DBT versus DBT+ACT)
|
At 12 months after the intervention
|
Evolution of para- suicidal symptomatology using the Columbia Suicide Severity Rating Scale (C-SSRS)
Time Frame: At one week after the intervention
|
Evaluation and comparison of para -suicidal symptomatology between pre-intervention and post-intervention (one week after the last session of the intervention) within the two groups (DBT versus DBT+ACT) with the 17 close-ended questions of the Columbia-Suicide severity rating scale
|
At one week after the intervention
|
Evolution of para- suicidal symptomatology using the Columbia Suicide Severity Rating Scale (C-SSRS)
Time Frame: At 6 months after the intervention
|
Evaluation and comparison of para -suicidal symptomatology between pre-intervention and post-intervention (one week after the last session of the intervention) within the two groups (DBT versus DBT+ACT)with the 17 close-ended questions of the Columbia-Suicide severity rating scale
|
At 6 months after the intervention
|
Evolution of para- suicidal symptomatology using the Columbia Suicide Severity Rating Scale (C-SSRS)
Time Frame: At 12 months after the intervention
|
Evaluation and comparison of para -suicidal symptomatology between pre-intervention and post-intervention (one week after the last session of the intervention) within the two groups (DBT versus DBT+ACT) with the 17 close-ended questions of the Columbia-Suicide severity rating scale
|
At 12 months after the intervention
|
Evolution of para-suicidal symptomatology (Likert scales from 0 (none) to 10 (maximum possible suicidal ideation)
Time Frame: At one week after the intervention
|
Evaluation and comparison of suicidal symptomatology between pre-intervention and post-intervention (one week after the last session of the intervention) within the two groups (DBT versus DBT+ACT
|
At one week after the intervention
|
Evolution of para-suicidal symptomatology (Likert scales from 0 (none) to 10 (maximum possible suicidal ideation)
Time Frame: At 6 months after the intervention
|
Evaluation and comparison of suicidal symptomatology between pre-intervention and post-intervention (one week after the last session of the intervention) within the two groups (DBT versus DBT+ACT
|
At 6 months after the intervention
|
Evolution of para-suicidal symptomatology (Likert scales from 0 (none) to 10 (maximum possible suicidal ideation)
Time Frame: At 12 months after the intervention
|
Evaluation and comparison of suicidal symptomatology between pre-intervention and post-intervention (one week after the last session of the intervention) within the two groups (DBT versus DBT+ACT
|
At 12 months after the intervention
|
Evolution of para-suicidal symptomatology (Likert scales from 0 (none) to 10 (maximal intensity of suicidal intent)
Time Frame: At one week after the intervention
|
Evaluation and comparison of intensity of suicidal intent between pre-intervention and post-intervention (one week after the last session of the intervention) within the two groups (DBT versus DBT+ACT)
|
At one week after the intervention
|
Evolution of para-suicidal symptomatology (Likert scales from 0 (none) to 10 (maximal intensity of suicidal intent)
Time Frame: At 6 months after the intervention
|
Evaluation and comparison of intensity of suicidal intent between pre-intervention and post-intervention (one week after the last session of the intervention) within the two groups (DBT versus DBT+ACT)
|
At 6 months after the intervention
|
Evolution of para-suicidal symptomatology (Likert scales from 0 (none) to 10 (maximal intensity of suicidal intent)
Time Frame: At 12 months after the intervention
|
Evaluation and comparison of intensity of suicidal intent between pre-intervention and post-intervention (one week after the last session of the intervention) within the two groups (DBT versus DBT+ACT)
|
At 12 months after the intervention
|
Evolution of para-suicidal symptomatology (Likert scales from 0 (none) to 10 (maximal intensity of imperious need for non-suicidal self-damaging behavior)
Time Frame: At one week after the intervention
|
Evaluation and comparison of intensity of imperious need for non-suicidal self-damaging behavior between pre-intervention and post-intervention (one week after the last session of the intervention) within the two groups (DBT versus DBT+ACT)
|
At one week after the intervention
|
Evolution of para-suicidal symptomatology (Likert scales from 0 (none) to 10 (maximal intensity of imperious need for non-suicidal self-damaging behavior)
Time Frame: At 6 months after the intervention
|
Evaluation and comparison of intensity of imperious need for non-suicidal self-damaging behavior between pre-intervention and post-intervention (one week after the last session of the intervention) within the two groups (DBT versus DBT+ACT)
|
At 6 months after the intervention
|
Evolution of para-suicidal symptomatology (Likert scales from 0 (none) to 10 (maximal intensity of imperious need for non-suicidal self-damaging behavior)
Time Frame: At 12 months after the intervention
|
Evaluation and comparison of intensity of imperious need for non-suicidal self-damaging behavior between pre-intervention and post-intervention (one week after the last session of the intervention) within the two groups (DBT versus DBT+ACT)
|
At 12 months after the intervention
|
Evolution of para-suicidal symptomatology (Likert scales from 0 (none) to 10 (maximal quality of perceived social support)
Time Frame: At one week after the intervention
|
Evaluation and comparison of quality of perceived social support between pre-intervention and post-intervention (one week after the last session of the intervention)within the two groups (DBT versus DBT+ACT)
|
At one week after the intervention
|
Evolution of para-suicidal symptomatology (Likert scales from 0 (none) to 10 (maximal quality of perceived social support)
Time Frame: At 6 months after the intervention
|
Evaluation and comparison of quality of perceived social support between pre-intervention and post-intervention (one week after the last session of the intervention)within the two groups (DBT versus DBT+ACT)
|
At 6 months after the intervention
|
Evolution of para-suicidal symptomatology (Likert scales from 0 (none) to 10 (maximal quality of perceived social support)
Time Frame: At 12 months after the intervention
|
Evaluation and comparison of quality of perceived social support between pre-intervention and post-intervention (one week after the last session of the intervention)within the two groups (DBT versus DBT+ACT)
|
At 12 months after the intervention
|
Evolution of para-suicidal symptomatology (Likert scales from 0 (none) to 10 (maximal psychological pain)
Time Frame: At one week after the intervention
|
Evaluation and comparison of psychological pain between pre-intervention and post-intervention (one week after of the last session of the intervention) within the two groups (DBT versus DBT+ACT)
|
At one week after the intervention
|
Evolution of para-suicidal symptomatology (Likert scales from 0 (none) to 10 (maximal psychological pain)
Time Frame: At 6 months after the intervention
|
Evaluation and comparison of psychological pain between pre-intervention and post-intervention (one week after of the last session of the intervention) within the two groups (DBT versus DBT+ACT)
|
At 6 months after the intervention
|
Evolution of para-suicidal symptomatology (Likert scales from 0 (none) to 10 (maximal psychological pain)
Time Frame: At 12 months after the intervention
|
Evaluation and comparison of psychological pain between pre-intervention and post-intervention (one week after of the last session of the intervention) within the two groups (DBT versus DBT+ACT)
|
At 12 months after the intervention
|
Evolution of para-suicidal symptomatology (Likert scales from 0 (not all characteristic of my way of being) to 10 (completely characteristic of my way of being)
Time Frame: At one week after the intervention
|
Evaluation and comparison of the evolution of intensity of each constituent trait of borderline personality disorder between pre-intervention and post-intervention (one week after the last session of the intervention) within the two groups (DBT versus DBT+ACT)
|
At one week after the intervention
|
Evolution of para-suicidal symptomatology (Likert scales from 0 (not all characteristic of my way of being) to 10 (completely characteristic of my way of being)
Time Frame: At 6 months after the intervention
|
Evaluation and comparison of the evolution of intensity of each constituent trait of borderline personality disorder between pre-intervention and post-intervention (one week after the last session of the intervention) within the two groups (DBT versus DBT+ACT)
|
At 6 months after the intervention
|
Evolution of para-suicidal symptomatology (Likert scales from 0 (not all characteristic of my way of being) to 10 (completely characteristic of my way of being)
Time Frame: At 12 months after the intervention
|
Evaluation and comparison of the evolution of intensity of each constituent trait of borderline personality disorder between pre-intervention and post-intervention (one week after the last session of the intervention) within the two groups (DBT versus DBT+ACT)
|
At 12 months after the intervention
|
Evolution of the borderline symptomatology using the Borderline Symptom List-23 (BSL-23) scale
Time Frame: At one week after the intervention
|
Evaluation and comparison of the evolution of the borderline symptomatology between pre-intervention and post-intervention (one week after the intervention) within the two groups (DBT versus DBT+ACT) with the 24 items of the Borderline Symptom List-23 (BSL-23) scale.
For every question, the subject has to choose a score from 0 to 4 (from not at all to very strongly)
|
At one week after the intervention
|
Evolution of the borderline symptomatology using the Borderline Symptom List-23 (BSL-23) scale
Time Frame: At 6 months after the intervention
|
Evaluation and comparison of the evolution of the borderline symptomatology between pre-intervention and post-intervention (one week after the intervention) within the two groups (DBT versus DBT+ACT) with the 24 items of the has to choose a score from 0 to 4 (from not at all to very strongly)
|
At 6 months after the intervention
|
Evolution of the borderline symptomatology using the Borderline Symptom List-23 (BSL-23) scale
Time Frame: At 12 months after the intervention
|
Evaluation and comparison of the evolution of the borderline symptomatology between pre-intervention and post-intervention (one week after the intervention) within the two groups (DBT versus DBT+ACT) with the 24 items of the Borderline Symptom List-23 (BSL-23) scale.
For every question, the subject has to choose a score from 0 to 4 (from not at all to very strongly)
|
At 12 months after the intervention
|
Evolution of emotional regulation abilities using the Difficulties in Emotion Regulation Scale (DERS)
Time Frame: At one week after the intervention
|
Evaluation and comparison of the evolution of emotional regulation abilities between pre-intervention and post-intervention (one week after the last session of the intervention) within the two groups (DBT versus DBT+ACT) with the 36 items of the Difficulties in Emotion Regulation Scale.
For every question, the subject has to choose a score from 1 to 5 (from almost never to almost always)
|
At one week after the intervention
|
Evolution of emotional regulation abilities using the Difficulties in Emotion Regulation Scale (DERS)
Time Frame: At 6 months after the intervention
|
Evaluation and comparison of the evolution of emotional regulation abilities between pre-intervention and post-intervention (one week after the last session of the intervention) within the two groups (DBT versus DBT+ACT) with the 36 items of the Difficulties in Emotion Regulation Scale.
For every question, the subject has to choose a score from 1 to 5 (from almost never to almost always)
|
At 6 months after the intervention
|
Evolution of emotional regulation abilities using the Difficulties in Emotion Regulation Scale (DERS)
Time Frame: At 12 months after the intervention
|
Evaluation and comparison of the evolution of emotional regulation abilities between pre-intervention and post-intervention (one week after the last session of the intervention) within the two groups (DBT versus DBT+ACT) with the 36 items of the Difficulties in Emotion Regulation Scale.
For every question, the subject has to choose a score from 1 to 5 (from almost never to almost always)
|
At 12 months after the intervention
|
Evolution of propensity to dissociation using the Dissociative Experience Scale (DES)
Time Frame: At one week after the intervention
|
Evaluation and comparison of the propensity to dissociation between pre-intervention and post-intervention (one week after the last session of the intervention) within the two groups (DBT versus DBT+ACT) with the 28 items of the Dissociative Experience Scale.
For every question, the subject has to choose a score from 0% to 100%.
|
At one week after the intervention
|
Evolution of propensity to dissociation using the Dissociative Experience Scale (DES)
Time Frame: At 6 months after the intervention
|
Evaluation and comparison of the propensity to dissociation between pre-intervention and post-intervention (one week after the last session of the intervention) within the two groups (DBT versus DBT+ACT) with the 28 items of the Dissociative Experience Scale.
For every question, the subject has to choose a score from 0% to 100%.
|
At 6 months after the intervention
|
Evolution of propensity to dissociation using the Dissociative Experience Scale (DES)
Time Frame: At 12 months after the intervention
|
Evaluation and comparison of the propensity to dissociation between pre-intervention and post-intervention (one week after the last session of the intervention) within the two groups (DBT versus DBT+ACT) with the 28 items of the Dissociative Experience Scale.
For every question, the subject has to choose a score from 0% to 100%.
|
At 12 months after the intervention
|
Anxiety state using the State-Trait Anxiety Inventory (STAI-Trait)
Time Frame: At one week after the intervention
|
Evaluation and comparison of the state of anxiety between pre-intervention and post-intervention (one week after the last session of the intervention) within the two groups (DBT versus DBT+ACT) with the 20 items of the State-Trait Anxiety Inventory (STAI-Trait).
For every question, the subject has to choose a score from 0 to 3 (from almost never to almost always)
|
At one week after the intervention
|
Anxiety state using the State-Trait Anxiety Inventory (STAI-Trait)
Time Frame: At 6 months after the intervention
|
Evaluation and comparison of the state of anxiety between pre-intervention and post-intervention (one week after the last session of the intervention) within the two groups (DBT versus DBT+ACT) with the 20 items of has to choose a score from 0 to 3 (from almost never to almost always)
|
At 6 months after the intervention
|
Anxiety state using the State-Trait Anxiety Inventory (STAI-Trait)
Time Frame: At 12 months after the intervention
|
Evaluation and comparison of the state of anxiety between pre-intervention and post-intervention (one week after the last session of the intervention) within the two groups (DBT versus DBT+ACT) with the 20 items of the State-Trait Anxiety Inventory (STAI-Trait).
For every question, the subject has to choose a score from 0 to 3 (from almost never to almost always)
|
At 12 months after the intervention
|
Anxiety state using the State-Trait Anxiety Inventory (STAI-State)
Time Frame: At one week after the intervention
|
Evaluation and comparison of the state of anxiety between pre-intervention and post-intervention (one week after the last session of the intervention) within the two groups (DBT versus DBT+ACT)with the 20 items of the State-Trait Anxiety Inventory (STAI-State).
For every question, the subject has to choose a score from 0 to 3 (from no to yes)
|
At one week after the intervention
|
Anxiety state using the State-Trait Anxiety Inventory (STAI-State)
Time Frame: At 6 months after the intervention
|
Evaluation and comparison of the state of anxiety between pre-intervention and post-intervention (one week after the last session of the intervention) within the two groups (DBT versus DBT+ACT) with the 20 items of the State-Trait Anxiety Inventory (STAI-State).
For every question, the subject has to choose a score from 0 to 3 (from no to yes)
|
At 6 months after the intervention
|
Anxiety state using the State-Trait Anxiety Inventory (STAI-State)
Time Frame: At 12 months after the intervention
|
Evaluation and comparison of the state of anxiety between pre-intervention and post-intervention (one week after the last session of the intervention) within the two groups (DBT versus DBT+ACT) with the 20 items of the State-Trait Anxiety Inventory (STAI-State).
For every question, the subject has to choose a score from 0 to 3 (from no to yes)
|
At 12 months after the intervention
|
Anger state using the Spielberger State-Trait Anger Expression Inventory (STAXI-TRAIT)
Time Frame: At 6 months after the intervention
|
Evaluation and comparison of the state of anger between pre-intervention and 6 months post-intervention within the two groups (DBT versus DBT+ACT) with the 33 items of Spielberger State-Trait Anger Expression Inventory (STAXI-TRAIT).
For every question, the subject has to choose a score from 1 to 4 (from almost never to almost always)
|
At 6 months after the intervention
|
Anger state using the Spielberger State-Trait Anger Expression Inventory (STAXI-TRAIT)
Time Frame: At 12 months after the intervention
|
Evaluation and comparison of the state of anger between pre-intervention and 6 months post-intervention within the two groups (DBT versus DBT+ACT) with the 33 items of Spielberger State-Trait Anger Expression Inventory (STAXI-TRAIT).
For every question, the subject has to choose a score from 1 to 4 (from almost never to almost always)
|
At 12 months after the intervention
|
Anger state using the Spielberger State-Trait Anger Expression Inventory (STAXI-ETAT)
Time Frame: At one week after the intervention
|
Evaluation and comparison of the state of anger between pre-intervention and 6 months post-intervention within the two groups (DBT versus DBT+ACT) with the 10 items of Spielberger State-Trait Anger Expression Inventory (STAXI-ETAT).
For every question, the subject has to choose a score from 1 to 4 (from not at all to a lot)
|
At one week after the intervention
|
Anger state using the Spielberger State-Trait Anger Expression Inventory (STAXI-ETAT)
Time Frame: At 6 months after the intervention
|
Evaluation and comparison of the state of anger between pre-intervention and 6 months post-intervention within the two groups (DBT versus DBT+ACT) with the 10 items of Spielberger State-Trait Anger Expression Inventory (STAXI-ETAT).
For every question, the subject has to choose a score from 1 to 4 (from not at all to a lot)
|
At 6 months after the intervention
|
Anger state using the Spielberger State-Trait Anger Expression Inventory (STAXI-ETAT)
Time Frame: At 12 months after the intervention
|
Evaluation and comparison of the state of anger between pre-intervention and 6 months post-intervention within the two groups (DBT versus DBT+ACT) with the 10 items of Spielberger State-Trait Anger Expression Inventory (STAXI-ETAT).
For every question, the subject has to choose a score from 1 to 4 (from not at all to a lot)
|
At 12 months after the intervention
|
Hopelessness using the Beck Hopelessness Scale (BHS)
Time Frame: At one week after the intervention
|
Evaluation and comparison of the hopelessness between pre-intervention and post-intervention (one week after the intervention) within the two groups (DBT versus DBT+ACT) with the 20 items of the Beck Hopelessness Scale.
For every question, the subject has to answer true or false
|
At one week after the intervention
|
Hopelessness using the Beck Hopelessness Scale (BHS)
Time Frame: At 6 months after the intervention
|
Evaluation and comparison of the hopelessness between pre-intervention and post-intervention (one week after the intervention) within the two groups (DBT versus DBT+ACT) with the 20 items of the Beck Hopelessness Scale.
For every question, the subject has to answer true or false
|
At 6 months after the intervention
|
Hopelessness using the Beck Hopelessness Scale (BHS)
Time Frame: At 12 months after the intervention
|
Evaluation and comparison of the hopelessness between pre-intervention and post-intervention (one week after the intervention) within the two groups (DBT versus DBT+ACT) with the 20 items of the Beck Hopelessness Scale.
For every question, the subject has to answer true or false.
|
At 12 months after the intervention
|
Quality Of Life evaluated by the World Health Organization Quality of Life measure (WHOQOL-BREF)
Time Frame: At one week after the intervention
|
Evaluation and comparison of the quality of life between pre-intervention and post-intervention (one week after the intervention) within the two groups (DBT versus DBT+ACT) with the 20 items of the World Health Organization Quality of Life measure (WHOQOL-BREF).
For every question, the subject has to choose a score from 1 to 5.
|
At one week after the intervention
|
Quality Of Life evaluated by the World Health Organization Quality of Life measure (WHOQOL-BREF)
Time Frame: At 6 months after the intervention
|
Evaluation and comparison of the quality of life between pre-intervention and post-intervention (one week after the intervention) within the two groups (DBT versus DBT+ACT) with the 20 items of the World Health Organization Quality of Life measure (WHOQOL-BREF).
For every question, the subject has to choose a score from 1 to 5.
|
At 6 months after the intervention
|
Quality Of Life evaluated by the World Health Organization Quality of Life measure (WHOQOL-BREF)
Time Frame: At 12 months after the intervention
|
Evaluation and comparison of the quality of life between pre-intervention and post-intervention (one week after the intervention) within the two groups (DBT versus DBT+ACT) with the 20 items of the World Health Organization Quality of Life measure (WHOQOL-BREF).
For every question, the subject has to choose a score from 1 to 5.
|
At 12 months after the intervention
|
Acceptance assessment using the Acceptance and Action Questionnaire (AAQII)
Time Frame: At one week after the intervention
|
Evaluation and comparison of the acceptance between pre-intervention and post-intervention (one week after the intervention) within the two groups (DBT versus DBT+ACT) with the 10 items of the Acceptance and Action Questionnaire (AAQII)).
For every question, the subject has to choose a score from 1 to 7(never true to always true).
|
At one week after the intervention
|
Acceptance assessment using the Acceptance and Action Questionnaire (AAQII)
Time Frame: At 6 months after the intervention
|
Evaluation and comparison of the acceptance between pre-intervention and post-intervention (one week after the intervention) within the two groups (DBT versus DBT+ACT) with the 10 items of the Acceptance and Action Questionnaire (AAQII)).
For every question, the subject has to choose a score from 1 to 7(never true to always true).
|
At 6 months after the intervention
|
Acceptance assessment using the Acceptance and Action Questionnaire (AAQII)
Time Frame: At 12 months after the intervention
|
Evaluation and comparison of the acceptance between pre-intervention and post-intervention (one week after the intervention) within the two groups (DBT versus DBT+ACT) with the 10 items of the Acceptance and Action Questionnaire (AAQII)).
For every question, the subject has to choose a score from 1 to 7(never true to always true).
|
At 12 months after the intervention
|
Contact with the present moment assessment using the Mindful Attention Awareness Scale (MAAS)
Time Frame: At one week after the intervention
|
Evaluation and comparison of the contact with the present moment between pre-intervention and post-intervention (one week after the intervention) within the two groups (DBT versus DBT+ACT) with the 15 items of Mindful Attention Awareness Scale (MAAS).
For every question, the subject has to choose a score from 1 to 6 (almost always to almost never).
|
At one week after the intervention
|
Contact with the present moment assessment using the Mindful Attention Awareness Scale (MAAS)
Time Frame: At 6 months after the intervention
|
Evaluation and comparison of the contact with the present moment between pre-intervention and post-intervention (one week after the intervention) within the two groups (DBT versus DBT+ACT) with the 15 items of Mindful Attention Awareness Scale (MAAS).
For every question, the subject has to choose a score from 1 to 6 (almost always to almost never).
|
At 6 months after the intervention
|
Contact with the present moment assessment using the Mindful Attention Awareness Scale (MAAS)
Time Frame: At 12 months after the intervention
|
Evaluation and comparison of the contact with the present moment between pre-intervention and post-intervention (one week after the intervention) within the two groups (DBT versus DBT+ACT) with the 15 items of Mindful Attention Awareness Scale (MAAS).
For every question, the subject has to choose a score from 1 to 6 (almost always to almost never).
|
At 12 months after the intervention
|
Meaning in life assessment using Life Regard Index (LRI)
Time Frame: At one week after the intervention
|
Evaluation and comparison of the contact with the present moment between pre-intervention and post-intervention (one week after the intervention) within the two groups (DBT versus DBT+ACT) with the 28 items of the Life Regard Index (LRI)).
For every question, the subject has to answer agree, neutral or ont agree
|
At one week after the intervention
|
Meaning in life assessment using Life Regard Index (LRI)
Time Frame: At 6 months after the intervention
|
Evaluation and comparison of the contact with the present moment between pre-intervention and post-intervention (one week after the intervention) within the two groups (DBT versus DBT+ACT) with the 28 items of the Life Regard Index (LRI)).
For every question, the subject has to answer agree, neutral or ont agree
|
At 6 months after the intervention
|
Meaning in life assessment using Life Regard Index (LRI)
Time Frame: At 12 months after the intervention
|
Evaluation and comparison of the contact with the present moment between pre-intervention and post-intervention (one week after the intervention) within the two groups (DBT versus DBT+ACT) with the 28 items of the Life Regard Index (LRI)).
For every question, the subject has to answer agree, neutral or ont agree
|
At 12 months after the intervention
|
Satisfaction of the intervention using the Likert scales rating from 0 (not at all satisfied) to 10 (extremely satisfied)
Time Frame: At one week after the intervention
|
Evaluation of the satisfaction about the intervention within the two groups (DBT versus DBT+ACT)
|
At one week after the intervention
|
Quality of life related to health using the EQ5D-3L questionnaire
Time Frame: At 6 months after the intervention
|
Evaluation and comparison of the quality of life between pre-intervention and 6 months post-intervention within the two groups (DBT versus DBT+ACT) with the 5 items of the EQ5D-3L.
For every question, the subject has the choice between 3 answers.
|
At 6 months after the intervention
|
Quality of life related to health using the EQ5D-3L questionnaire
Time Frame: At 12 months after the intervention
|
Evaluation and comparison of the quality of life between pre-intervention and 6 months post-intervention within the two groups (DBT versus DBT+ACT) with the 5 items of the EQ5D-3L.
For every question, the subject has the choice between 3 answers.
|
At 12 months after the intervention
|
Depression intensity using the Inventory of Depressive Symptomatology (IDS-C30)
Time Frame: At one week after the intervention
|
Evaluation and comparison of the intensity of depression between pre-intervention and post-intervention (one week after the last session) within the two groups (DBT versus DBT+ACT) with the 30 items of Inventory of Depressive Symptomatology (IDS-C30).
For every item corresponding to a depressive symptom, the investigator has the choice between 3 levels of response.
|
At one week after the intervention
|
Depression intensity using the Inventory of Depressive Symptomatology (IDS-C30)
Time Frame: At 6 months after the intervention
|
Evaluation and comparison of the intensity of depression between pre-intervention and post-intervention (one week after the last session) within the two groups (DBT versus DBT+ACT) with the 30 items of Inventory of Depressive Symptomatology (IDS-C30).
For every item corresponding to a depressive symptom, the investigator has the choice between 3 levels of response.
|
At 6 months after the intervention
|
Depression intensity using the Inventory of Depressive Symptomatology (IDS-C30)
Time Frame: At 12 months after the intervention
|
Evaluation and comparison of the intensity of depression between pre-intervention and post-intervention (one week after the last session) within the two groups (DBT versus DBT+ACT) with the 30 items of Inventory of Depressive Symptomatology (IDS-C30).
For every item corresponding to a depressive symptom, the investigator has the choice between 3 levels of response.
|
At 12 months after the intervention
|
Global functioning using the Global Assessment of Functioning Scale (GAF)
Time Frame: At one week after the intervention
|
Evaluation and comparison of the global functioning between pre-intervention and post-intervention (one week after the intervention) within the two groups (DBT versus DBT+ACT) with the Global Assessment of Functioning Scale (GAF).With this scale, the investigator has to give a score between 0 to 100 for the global functioning of the patient
|
At one week after the intervention
|
Global functioning using the Global Assessment of Functioning Scale (GAF)
Time Frame: At 6 months after the intervention
|
Evaluation and comparison of the global functioning between pre-intervention and post-intervention (one week after the intervention) within the two groups (DBT versus DBT+ACT) with the Global Assessment of Functioning Scale (GAF).With this scale, the investigator has to give a score between 0 to 100 for the global functioning of the patient
|
At 6 months after the intervention
|
Global functioning using the Global Assessment of Functioning Scale (GAF)
Time Frame: At 12 months after the intervention
|
Evaluation and comparison of the global functioning between pre-intervention and post-intervention (one week after the intervention) within the two groups (DBT versus DBT+ACT) with the Global Assessment of Functioning Scale (GAF).With this scale, the investigator has to give a score between 0 to 100 for the global functioning of the patient
|
At 12 months after the intervention
|
Incremental cost-effectiveness ratio (ICER)
Time Frame: At 1 year follow-up
|
Evaluation and comparison of the incremental cost-effectiveness ratio between pre-intervention and 12 months post-intervention within the two groups (DBT versus DBT+ACT)
|
At 1 year follow-up
|
Incremental cost-utility ratio (ICUR)
Time Frame: At 1 year follow-up
|
Evaluation and comparison of the incremental cost-utility ratio between pre-intervention and 12 months post-intervention within the two groups (DBT versus DBT+ACT)
|
At 1 year follow-up
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- RECHMPL18_0044
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Female
-
Alexandria UniversityCompleted
-
Alexandria UniversityCompletedFemale InfertilityEgypt
-
Istituto Clinico HumanitasIRCCS San RaffaeleCompleted
-
Bharat Serums and Vaccines LimitedActive, not recruitingFemale InfertilityIndia
-
Uppsala UniversityMalmö UniversityCompletedFemale Circumcision | Female Genital Mutilation/CuttingSweden
-
Peking University Third HospitalRecruiting
-
Nadezhda Women's Health HospitalMedical diagnostic laboratory ImunoVitaRecruitingFemale InfertilityBulgaria
-
Università Vita-Salute San RaffaeleRecruitingFemale InfertilityItaly
-
Alexandria UniversityCompleted
-
Rennes University HospitalCompleted
Clinical Trials on DBT+ACT
-
University of WashingtonNational Institute of Mental Health (NIMH)CompletedSuicide | Borderline Personality DisorderUnited States
-
Rivierduinen, Centre for Personality disorders...Erasmus Medical CenterUnknownBorderline Personality DisorderNetherlands
-
Haukeland University HospitalRecruitingSuicidal Ideation | Self-harm | Suicide and Self-harmNorway
-
University of Maryland, BaltimoreRecruitingSuicide | PsychosisUnited States
-
Rutgers, The State University of New JerseyActive, not recruitingBorderline Personality Disorder in AdolescenceUnited States
-
Mental Health Services in the Capital Region, DenmarkUniversity of Copenhagen; Lundbeck FoundationCompletedSuicide | Borderline Personality DisorderDenmark
-
ArkinAmsterdam UMC, location VUmc; Ziekenhuis Amstelland; Meander Medisch Centrum; Sinai... and other collaboratorsRecruitingPosttraumatic Stress Disorder (PTSD) | Borderline Personality Disorder (BPD)Netherlands
-
Bowling Green State UniversityUnknownOverweight and Obesity | Emotional Eating
-
University of MinnesotaWithdrawn
-
King's College LondonSouth London and Maudsley NHS Foundation TrustNot yet recruiting